{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:17:32Z","timestamp":1791152252766,"version":"4.1.0"},"reference-count":26,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> The immunopathogenesis of hepatitis B e antigen (HBeAg) negative chronic hepatitis B (CHB) virus (HBV) infection has not been adequately investigated. We studied the cellular immune responses of peripheral lymphocytes using proliferating assays, intracellular cytokine staining (ICS) and ELISPOT interferon\u2010\u03b3 (IFN\u2010\u03b3) assays after non\u2010specific and specific stimulation with whole HBV proteins and synthetic peptides. Thirty patients with HBeAg negative CHB, eleven HBsAg inactive carriers, nine patients with acute hepatitis B and 22 healthy controls were included in the study. Patients with HBeAg negative CHB demonstrated an increased number of peripheral CD8+ T cells while their peripheral blood mononuclear cells showed increased proliferation after <jats:italic>in vitro<\/jats:italic> stimulation with overlapping hepatitis B core derived peptides and an envelope derived epitope (HBs 182\u2013191\u2003aa), similar to those observed in acute hepatitis B. Using ICS, we found an expanded population of IFN\u2010\u03b3 producing T lymphocytes, CD4+ and CD8+, after non\u2010specific stimulation, in HBeAg negative CHB compared to all other groups. HBeAg negative CHB and acute hepatitis B patients had a similarly increased number of core specific T cells measured by the IFN\u2010\u03b3 assays. Inactive HBsAg carriers showed minimal proliferative responses overall while they exhibited an increased number of envelope specific effector T cells (measured by ICS). In conclusion, we showed that overall CD4+ T cell responses from patients with HBeAg negative CHB were comparable to those of acute hepatitis B, while inactive HBsAg carriers despite their limited proliferative capacity the effector activity of their peripheral T cells was maintained.<\/jats:p>","DOI":"10.1111\/j.1365-2893.2008.00996.x","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T00:49:05Z","timestamp":1213231745000},"page":"817-826","source":"Crossref","is-referenced-by-count":12,"title":["Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B"],"prefix":"10.1111","volume":"15","author":[{"given":"D.","family":"Vassilopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Rapti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hadziyannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Hadziyannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.000333"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50310"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1573"},{"key":"e_1_2_6_5_2","first-page":"7","article-title":"Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment","volume":"1","author":"Hadziyannis SJ","year":"1995","journal-title":"Viral Hepat Rev"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20956"},{"issue":"1","key":"e_1_2_6_7_2","first-page":"S3","article-title":"EASL International Consensus Conference on Hepatitis B. 13\u201014 September, 2002 Geneva, Switzerland. Consensus statement (long version)","volume":"39","author":"De Franchis R","year":"2003","journal-title":"J Hepatol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21513"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27834"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50352"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00304.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(01)00173-5"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80226-6"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80334-1"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.9.5863"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(84)90414-3"},{"key":"e_1_2_6_17_2","first-page":"57S","article-title":"T cell subsets in autoimmune and HBV\u2010induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment","volume":"2","author":"Thomas HC","year":"1982","journal-title":"J Clin Immunol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(86)90312-6"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1128\/jvi.70.11.7540-7548.1996","article-title":"Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core\u2010specific CD4+ T cells in vitro","volume":"70","author":"Diepolder HM","year":"1996","journal-title":"J Virol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus\u2010encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari C","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90074-L"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.69.6.3358-3368.1995"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9833"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220110"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220405"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(03)00199-2"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.8.1269"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2008.00996.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.2008.00996.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T02:34:55Z","timestamp":1696991695000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2008.00996.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,24]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1365-2893.2008.00996.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2008.00996.x","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,24]]}}}